Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between

Diana Moldovan1, Ioan Moldovan, Crina Rusu

  • 1Mihai Manasia Nephrology and Dialysis Clinic Cluj-Napoca, University of Medicine and Pharmacy Cluj-Napoca, Nephrology Clinic 3-5 Clinics Street, 400006 Cluj-Napoca, Romania. Diana.Moldovan@umfcluj.ro

Insights

Vascular calcifications (VCs) and renal osteodystrophy (ROD) are common in hemodialysis patients. ROD, male gender, and calcium salt treatment are risk factors for developing VCs, suggesting a link between bone and artery disease.

Area of Science:

  • Nephrology
  • Cardiology
  • Bone Metabolism

Background:

  • Vascular calcifications (VCs) and renal osteodystrophy (ROD) are prevalent complications in hemodialysis (HD) patients.
  • These conditions significantly contribute to morbidity and mortality in this population.
  • A potential pathogenic link between VCs and ROD remains debated.

Purpose of the Study:

  • To investigate the relationship between VCs and ROD in chronic HD patients.
  • To evaluate the prevalence of VCs and ROD.
  • To identify clinical and biochemical factors associated with VCs in HD patients.

Main Methods:

  • Radiological assessment of VCs and ROD using hand and pelvis bone radiographs in 81 chronic HD patients.
  • Calculation of a vascular calcification (VC) score.
  • Correlation and regression analyses to determine associations between VCs, ROD, and clinical/biochemical parameters.

Main Results:

  • A significant association was found between radiological signs of ROD and VCs (P = 0.019).
  • Patients with ROD exhibited a higher mean VC score (P = 0.02).
  • VC score correlated with serum calcium, phosphorus, iPTH, CaxP product, and inversely with albumin. ROD, male gender, and calcium salt treatment predicted VCs.

Conclusions:

  • A pathogenic link between bone disease (ROD) and arterial disease (VCs) is suggested in chronic HD patients.
  • Both VCs and ROD are highly prevalent in this cohort.
  • ROD, male gender, and calcium salt treatment are identified as risk factors for VCs.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...